To address the challenges of discovery and development for novel molecules, Eurofins Discovery regularly invests in people, technology, and innovation to build a global, integrated organization that offers valuable knowledge and experience to progress your drug discovery programs.
Whether you are investigating small molecules or biotherapeutics, Eurofins Discovery is with you every step of the way in translational study design and services to quickly deliver a promising, robust pre-clinical candidate. Our expertise in all major target classes and therapeutic areas guide understanding in mode-of-action (MOA), target-based and phenotypic profiling, in vitro secondary and safety pharmacology and pharmacokinetic/pharmacodynamics (PK/PD) assessment that will inform your molecules’ pathway engagement in human biological systems, potency, and selectivity.
